The UC Davis Alzheimer's Disease Center (ADCC) represents a collaborative effort by investigators and clinicians at the University of California, Davis and the Lawrence Berkeley Laboratory. For the past 5 years, these groups have been working together using a variety of techniques to study patients with Alzheimer's disease (AD). The overall scientific goal of this program, relating the neurobehavioral features of the disease to its neurobiology, will be advanced by the ADCC, which will integrate and expand a host of clinical and research activities currently ongoing. Important aspects of the program include careful and uniform cognitive and behavioral evaluations of a large cohort of patients and control subjects, yearly longitudinal follow-up, ultimate neuropathological examination, and management of a data base containing all of this information. The program will utilize 5 existing clinics to refer patients to the ADCC. Two of these referral clinics with a long history of collaboration are State of California funded Alzheimer's Disease Diagnostic and Treatment Centers (ADDTCs), located in Berkeley and Sacramento. Patients will also be referred from two county hospital clinics and a VA hospital clinic. This integrated network will make the ADCC accessible to a large and diverse population extending from the San Francisco Bay Area through the Central Valley to the Sierra Foothills and the Oregon border. In order to accommodate this large geographic catchment area, the ADCC will have two clinical performance sites in Berkeley and Sacramento, utilizing shared personnel and joint training and clinical activities to ensure uniformity of data collection. This system will be supervised by a centralized administrative core to ensure maintenance of clinical, programmatic, and scientific goals. Clinical data, comprising the results of the history, physical and neurological examination, laboratory evaluation, neuroimaging results, and the detailed behavioral and cognitive assessment, will be collected, coded, stored, and analyzed uniformly. This data base, available to all investigators, will greatly enhance the capacity for collaborative projects. Neuropathological examination will be ensured by longitudinal follow-up and enhancement of a system which has already proven effective. Autopsy services will be provided locally, with quickly dispatched dissectors available to process tissue for a number of types of studies. All tissue will be studied in Sacramento, with detailed and quantitative neuropathological results entered into the data base. Tissue processed in a number of ways will also be available to investigators. These collective functions of the ADCC will be enhanced through activities focused upon training researchers and clinicians, promoting the ADCC within the University and community in order to recruit new investigators and patients, and increasing interactions between researchers, clinicians, and members of the University community in general.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Center Core Grants (P30)
Project #
Application #
Study Section
Neuroscience, Behavior and Sociology of Aging Review Committee (NBSA)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Davis
Schools of Medicine
United States
Zip Code
Weintraub, Sandra; Besser, Lilah; Dodge, Hiroko H et al. (2018) Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord 32:10-17
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
Wilmoth, Kristin; LoBue, Christian; Clem, Matthew A et al. (2018) Consistency of traumatic brain injury reporting in older adults with and without cognitive impairment. Clin Neuropsychol 32:524-529
Liu, Mingxia; Zhang, Jun; Adeli, Ehsan et al. (2018) Landmark-based deep multi-instance learning for brain disease diagnosis. Med Image Anal 43:157-168
Ting, Simon Kang Seng; Foo, Heidi; Chia, Pei Shi et al. (2018) Dyslexic Characteristics of Chinese-Speaking Semantic Variant of Primary Progressive Aphasia. J Neuropsychiatry Clin Neurosci 30:31-37
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Jena, Prasant Kumar; Sheng, Lili; Di Lucente, Jacopo et al. (2018) Dysregulated bile acid synthesis and dysbiosis are implicated in Western diet-induced systemic inflammation, microglial activation, and reduced neuroplasticity. FASEB J 32:2866-2877
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25
Maezawa, Izumi; Nguyen, Hai M; Di Lucente, Jacopo et al. (2018) Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept. Brain 141:596-612
Meyer, Oanh L; Liu, Xiaoyan Lucia; Tancredi, Daniel et al. (2018) Acculturation level and caregiver outcomes from a randomized intervention trial to enhance caregivers' health: evidence from REACH II. Aging Ment Health 22:730-737

Showing the most recent 10 out of 1156 publications